MDDI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Supplier Stories for the Week of August 18

Here’s what was new in the world of medical device suppliers during the week of August 18.

  • MICRO has opened its state-of-the-art 15,000-sq-ft R&D center inside the company’s recently purchased 50,000-sq-ft building in Somerset, NJ. The R&D Center was dedicated in honor of company Chairman Frank Semcer Sr. (shown above at center) to recognize his 50 years of leadership, the company reported in a news release. Semcer Sr. began with MICRO in 1969 (working under his father) and has helped grow MICRO from a small manufacturer of metal stampings to a global provider of medical device contract manufacturing services.

    Semcer Sr. is a member of The New Jersey Technology & Manufacturing Association, the Society of Manufacturing Engineers, and the American Society of Quality Control. He serves on the Board of Stevens Institute of Technology, receiving the Harold R. Fee ’20 Alumni Achievement Award in 1985 and the Stevens Honor Award in Innovation and Entrepreneurship in 2010.

    MICRO's new building will also serve as the company's headquarters, enabling it to optimize manufacturing space in its other two locations next door. The company stated that its expansion reinforces its mission to provide “Manufacturing Solutions For Life.”

    In addition to providing innovative solutions to the medical device industry, MICRO has recently expanded into the robotic-assisted surgery market.

    [Shown in above image from left to right: Alfred Carolonza (Director of Marketing Research & Strategy), Brian Semcer (President), Frank Semcer Sr., (Chairman), Paige McCann (Shareholder and Manufacturing Coordinator), and Frank Semcer Jr. (Director of Human Resources). Image courtesy of MICRO]

  • Plexus's Azteca Manufacturing facility, which is located in Guadalajara, Mexico, has achieved FDA approval to manufacture finished Class III medical devices.

    “Class III medical registration represents the ability to manufacture the highest risk medical devices, as these products sustain and save lives. There is no tolerance for failure for these types of products," stated Michael Tendick, Plexus Market Sector Vice President – Healthcare and Life Sciences, in a news release. "Plexus is pleased to continue to add to its global footprint of facilities, which offer the leading edge reliability, quality, technological capabilities, and teams required to create these highly complex and regulated products.”

    In addition to manufacturing, Plexus offers value-add services including product development and supply chain and aftermarket services. It can help customers improve time-to-market and achieve cost competitiveness.

    The Azteca Manufacturing facility is Plexus’s fourth global manufacturing facility to achieve the accreditation, which requires customer sponsorship, rigorous clinical data analysis, and exceptional focus on quality and manufacturing capabilities, the company reported in the release.

    [Image courtesy of PLEXUS]

  • Ultra Machining Company (UMC) has entered into a Letter of Intent with the City of Monticello Economic Development Authority (EDA) in Minnesota on the potential expansion of its facility at 500 Chelsea Road East. UMC is a family-owned company that produces highly complex parts for the medical, aerospace, and commercial industries.

    “Our current and future demand from key customers in the medical and aerospace industries are pushing the need to develop a new production facility to relieve capacity pressure at our existing site,” said Jaci Dukowitz, COO at UMC, in a news release. “The expansion will allow the incorporation of new processes, products, and customers. It’s an integral part of our next phase of growth and we’re excited to be embarking on this initiative.”

    Working in partnership with the city of Monticello, EDA will seek to acquire land and implement economic development incentives to support the development. Tentatively planned to begin in late 2019 or early 2020, the expansion is intended to occur adjacent to UMC's current facility and would create a campus setting for more efficiency with its workforce and production processes. 

    UMC is one of Monticello’s largest employers, the company reported, and it expects to generate 60 new jobs within the first 3 years of the expansion and generate a new tax base through the construction of a new 40,000-sq-ft facility. The facility could eventually grow to approximately 85,000-sq-ft with future employment at the site reaching 100 to 125 jobs, the company stated.

    [Image courtesy of ULTRA MACHINING COMPANY]

  • DWK Life Sciences is offering a collection of packaging products and services designed to enhance security and minimize waste of high-value diagnostic products. The Packaging and Production Workflow Solution includes NextGen V and E-Z Ex-Traction vials along with closure systems consisting of stoppers, seals, and caps. The company also offers a range of pretreatment and preparation services to meet customer applications.

    “Customers responded immediately to our Packaging and Production Workflow Solution featuring High Recovery Containment systems, so we made the services available for our other products used in the clinical and diagnostic market,” said Rick Schwartz, senior vice president of sales and marketing at DWK Life Sciences, in a news release. “This suite of services and capabilities is available for our line of vials and dropper bottles as well."

    Both the Wheaton NextGen V Vials and the E-Z Ex-Traction Vials feature specialty wells for maximizing sample recovery. Both vials are made from low-extractable chemically resistant borosilicate glass that meets USP Type 1 and ASTM E 438 Type 1 Class A requirements, the company reported.

    Closure choices include screw caps made from phenolic or polypropylene or aluminum crimp caps, both of which accommodate 14B Styrene-Butadiene or bonded PTFE-faced silicon liners, or latex-free bromobutyl stoppers, it was reported. 

    Customers can choose from custom services such as particulate cleaning with a choice of USP or WFI compliant rinses, endotoxin inactivation by depyrogenation to meet USP and FDA standards, sterilization by gamma irradiation or other methods, siliconization and silanization for minimizing interactions between product and container, application of customer-specified bar codes, and providing the vial and closure with a tare weight for precise filling and weighing.

    Vials can be shipped in bulk pack configurations, shrink-wrapped in a low-particulate cellular tray to ensure that they maintain a high level of cleanliness, and delivered ready-to-use with USP certifications for traceability.


  • A universal oven from The Grieve Corp., No. 841, can be used for a variety of heat treatments up to 650°F (343°C) at the customer’s facility.

    Measuring 36 in. W x 36 in. D x 36 in. H in terms of workspace, the oven features 6-in. insulated walls, an aluminized steel exterior, and a Type 430 stainless steel interior with double doors. Additional features include a workspace floor reinforced for 500 lb loading at removable subway grate and an integral leg stand.

    Controls on the No. 841 include a digital programming temperature controller, manual reset excess temperature controller with separate contactors, and a recirculating blower airflow safety switch.

    [Image courtesy of THE GRIEVE CORP.]


  • Boston Centerless, a supplier of precision ground alloys and services to the medical device industry, announces the appointment of Impact Ireland <Metals> Ltd. as the exclusive distributor of precision bar products to the medical device market for the Republic of Ireland and the United Kingdom. 

    “By adding Boston Centerless to Impact Ireland <Metals> Ltd. product offering, we enhance the products and services offered to our customers while helping them improve their products and reduce costs,” said Impact Ireland <Metals> Ltd. Chairman and CEO Don Clarke in a news release.

    Impact Ireland <Metals> Ltd. will play an instrumental role in establishing a presence for Boston Centerless in Ireland. “There could not be a better partner for us in Ireland and the UK,” said David Smith, vice president of business development for Boston Centerless, in the statement. “Impact Ireland <Metals> Ltd. knowledge of the Irish medical device market, existing infrastructure and vast experience working with European organizations is unsurpassed. Impact Ireland <Metals> Ltd. also possesses the local resources and high quality service standards that Boston Centerless is known for.”

    Added Steven Tamasi, CEO of Boston Centerless: “As part of our growth strategy, Boston Centerless has not only opened multiple distribution centers to service the entire US, but has also expanded into the People’s Republic of China and other East Asia nations. Growing and supporting our customer base in Ireland was a natural next step.”

    [Logo courtesy of BOSTON CENTERLESS]

Daphne Allen

Daphne Allen is editor-in-chief of MD+DI. She previously served as executive editor of Pharmaceutical & Medical Packaging News, which serves as the pharmaceutical and medical device channel of Packaging Digest. Daphne has covered medical device manufacturing, packaging, labeling, and regulatory issues as well as pharmaceutical packaging and labeling for more than 20 years. She is also a member of the Institute of Packaging Professionals's Medical Device Packaging Technical Committee. Follow her on Twitter at @daphneallen.


500 characters remaining